The Cancer Research Institute invites letters of intent for its clinic and laboratory integration programme grants. These support scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. Grants support basic, preclinical, and translational research that can be directly applied to optimising cancer immunotherapy in the clinic.
Funding & Duration
Grants are worth up to USD $100,000 (approx. AUD $136,000) each per year for two years. Funding covers salary, technical assistance, supplies, capital equipment or scientific travel costs. Indirect costs are not covered.
Candidates must be qualified scientists who hold a faculty appointment as a tenure-track assistant professor, or higher rank, at the time of the award activation. There are no citizenship requirements for candidates, and research may be conducted at medical schools and research centres throughout the world.
For-profit institutions are ineligible.
Submission Requirements & Due Dates
- 1 November 2018 – Letter of Intent (LOI) submitted to Sponsor
- 25 January 2019 – full applications submitted for internal review.
- Please email email@example.com if you are considering applying for this scheme
- See also: Submitting an Application to Research Services for Review